Intestine-specific FXR agonists as potential therapeutic agents for colorectal cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intestine-specific FXR agonists as potential therapeutic agents for colorectal cancer
Authors
Keywords
Colorectal cancer, Farnesoid X receptor, Intestine-restricted FXR agonists, Mechanism
Journal
BIOCHEMICAL PHARMACOLOGY
Volume 186, Issue -, Pages 114430
Publisher
Elsevier BV
Online
2021-02-07
DOI
10.1016/j.bcp.2021.114430
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cilofexor, a Nonsteroidal FXR Agonist, in Non‐Cirrhotic Patients with Nonalcoholic Steatohepatitis: A Phase 2 Randomized Controlled Trial
- (2020) Keyur Patel et al. HEPATOLOGY
- Bile Acids Signal via TGR5 to Activate Intestinal Stem Cells and Epithelial Regeneration
- (2020) Giovanni Sorrentino et al. GASTROENTEROLOGY
- Dietary Choices Modulate Colorectal Cancer Stem Cells: A Role of FXR Nuclear Receptor
- (2020) Nilesh Kumar Sharma et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Farnesoid X receptor antagonizes Wnt/β-catenin signaling in colorectal tumorigenesis
- (2020) Junhui Yu et al. Cell Death & Disease
- The nonsteroidal FXR agonist cilofexor (GS-9674) improves markers of cholestasis and liver injury in patients with PSC
- (2019) Michael Trauner et al. HEPATOLOGY
- TGR5 Protects Against Colitis in Mice, but Vertical Sleeve Gastrectomy Increases Colitis Severity
- (2019) Darline Garibay et al. OBESITY SURGERY
- Angiogenin promotes colorectal cancer metastasis via tiRNA production
- (2019) Siqi Li et al. INTERNATIONAL JOURNAL OF CANCER
- FXR Regulates Intestinal Cancer Stem Cell Proliferation
- (2019) Ting Fu et al. CELL
- Farnesoid X receptor represses matrix metalloproteinase 7 expression, revealing this regulatory axis as a promising therapeutic target in colon cancer
- (2019) Zhongsheng Peng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Genistein protects against DSS-induced colitis by inhibiting NLRP3 inflammasome via TGR5-cAMP signaling
- (2019) Yu Chen et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- The gut microbiota at the intersection of bile acids and intestinal carcinogenesis: An old story, yet mesmerizing
- (2019) Tianyu Liu et al. INTERNATIONAL JOURNAL OF CANCER
- High Sensitivity to Cholic Acid-induced Colonic Tumorigenesis Makes Female PIRC Rats (F344/NTac-Apcam1137) a Suitable Model for Studying CRC-promoting Agents
- (2019) CRISTINA LUCERI et al. ANTICANCER RESEARCH
- P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAs
- (2019) Yuechao Zhao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development
- (2019) Juliette Mouries et al. JOURNAL OF HEPATOLOGY
- Ursodeoxycholic acid is a GPBAR1 agonist and resets liver/intestinal FXR signaling in a model of diet-induced dysbiosis and NASH
- (2019) Adriana Carino et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Colorectal cancer
- (2019) Evelien Dekker et al. LANCET
- The protective effect of lithocholic acid on the intestinal epithelial barrier is mediated by the vitamin D receptor via a SIRT1/Nrf2 and NF-κB dependent mechanism in Caco-2 cells
- (2019) Baiyu Yao et al. TOXICOLOGY LETTERS
- Germline Polymorphisms in the Nuclear Receptors PXR and VDR as Novel Prognostic Markers in Metastatic Colorectal Cancer Patients Treated With FOLFIRI
- (2019) Elena De Mattia et al. Frontiers in Oncology
- Impact of obeticholic acid on the lipoprotein profile in patients with non-alcoholic steatohepatitis
- (2019) Mohammad Shadab Siddiqui et al. JOURNAL OF HEPATOLOGY
- Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism
- (2018) Preeti Pathak et al. HEPATOLOGY
- Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice
- (2018) Phillipp Hartmann et al. HEPATOLOGY
- Update on FXR Biology: Promising Therapeutic Target?
- (2018) Chang Han INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Deoxycholic acid activates epidermal growth factor receptor and promotes intestinal carcinogenesis by ADAM17-dependent ligand release
- (2018) Wenxiao Dong et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Mechanisms of action of vitamin D in colon cancer
- (2018) Gemma Ferrer-Mayorga et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer
- (2018) Ying Zhang et al. Molecular Cancer
- Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis: a role for bifidobacteria and lactobacilli?
- (2018) Borja Sánchez Nature Reviews Gastroenterology & Hepatology
- Colorectal cancer patients with different C-reactive protein levels and 5-year survival times can be differentiated with quantitative serum proteomics
- (2018) Matilda Holm et al. PLoS One
- Adipose tissue inflammation and VDR expression and methylation in colorectal cancer
- (2018) Daniel Castellano-Castillo et al. Clinical Epigenetics
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- FXR modulators for enterohepatic and metabolic diseases
- (2018) Hong Wang et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- FXR-Dependent Modulation of the Human Small Intestinal Microbiome by the Bile Acid Derivative Obeticholic Acid
- (2018) Elliot S. Friedman et al. GASTROENTEROLOGY
- Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer
- (2017) Inés Mármol et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Bile acids and colon cancer: Is FXR the solution of the conundrum?
- (2017) Raffaella Maria Gadaleta et al. MOLECULAR ASPECTS OF MEDICINE
- Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
- (2017) Wei Jia et al. Nature Reviews Gastroenterology & Hepatology
- Repression of intestinal transporters and FXR-FGF15 signaling explains bile acids dysregulation in experimental colitis-associated colon cancer
- (2017) Lijuan Cao et al. Oncotarget
- Comparison of Targeted vs Random Biopsies for Surveillance of Ulcerative Colitis-Associated Colorectal Cancer
- (2016) Toshiaki Watanabe et al. GASTROENTEROLOGY
- Fxr Agonism by Gs-9674 Decreases Steatosis and Fibrosis in a Murine Model of Nash
- (2016) J.T. Liles et al. JOURNAL OF HEPATOLOGY
- Discovery of 3α,7α,11β-Trihydroxy-6α-ethyl-5β-cholan-24-oic Acid (TC-100), a Novel Bile Acid as Potent and Highly Selective FXR Agonist for Enterohepatic Disorders
- (2016) Roberto Pellicciari et al. JOURNAL OF MEDICINAL CHEMISTRY
- Colonic inflammation accompanies an increase of β-catenin signaling and Lachnospiraceae / Streptococcaceae bacteria in the hind gut of high-fat diet-fed mice
- (2016) Huawei Zeng et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Pregnane X-receptor promotes stem cell-mediated colon cancer relapse
- (2016) Chris Planque et al. Oncotarget
- Bile acid: a potential inducer of colon cancer stem cells
- (2016) Lulu Farhana et al. Stem Cell Research & Therapy
- The FXR Agonist Obeticholic Acid Prevents Gut Barrier Dysfunction and Bacterial Translocation in Cholestatic Rats
- (2015) Len Verbeke et al. AMERICAN JOURNAL OF PATHOLOGY
- Tissue-specific actions of FXR in metabolism and cancer
- (2015) Raffaella Maria Gadaleta et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Bile acids as metabolic regulators
- (2015) Tiangang Li et al. CURRENT OPINION IN GASTROENTEROLOGY
- Gut Microbiota, Cirrhosis, and Alcohol Regulate Bile Acid Metabolism in the Gut
- (2015) Jason M. Ridlon et al. DIGESTIVE DISEASES
- Bile Acids as Hormones: The FXR-FGF15/19 Pathway
- (2015) Steven A. Kliewer et al. DIGESTIVE DISEASES
- Transgenic Expression of Vitamin D Receptor in Gut Epithelial Cells Ameliorates Spontaneous Colitis Caused by Interleukin-10 Deficiency
- (2015) Maya Aharoni Golan et al. DIGESTIVE DISEASES AND SCIENCES
- MiR-22-silenced Cyclin A Expression in Colon and Liver Cancer Cells Is Regulated by Bile Acid Receptor
- (2015) Fan Yang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity
- (2015) Michaela Mueller et al. JOURNAL OF HEPATOLOGY
- Inactivation of Adenomatous Polyposis Coli Reduces Bile Acid/Farnesoid X Receptor Expression through Fxr gene CpG Methylation in Mouse Colon Tumors and Human Colon Cancer Cells
- (2015) Ornella I Selmin et al. JOURNAL OF NUTRITION
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- Sequential cancer mutations in cultured human intestinal stem cells
- (2015) Jarno Drost et al. NATURE
- Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance
- (2015) Sungsoon Fang et al. NATURE MEDICINE
- The G-Protein-Coupled Bile Acid Receptor Gpbar1 (TGR5) Inhibits Gastric Inflammation Through Antagonizing NF-κB Signaling Pathway
- (2015) Cong Guo et al. Frontiers in Pharmacology
- Dismicrobism in inflammatory bowel disease and colorectal cancer: Changes in response of colocytes
- (2015) Giovanni Tomasello WORLD JOURNAL OF GASTROENTEROLOGY
- Nuclear bile acid signaling through the farnesoid X receptor
- (2014) Claire Mazuy et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Intestinal transport and metabolism of bile acids
- (2014) Paul A. Dawson et al. JOURNAL OF LIPID RESEARCH
- PPARα-UGT axis activation represses intestinal FXR-FGF15 feedback signalling and exacerbates experimental colitis
- (2014) Xueyan Zhou et al. Nature Communications
- FXR silencing in human colon cancer by DNA methylation and KRAS signaling
- (2013) Ann M. Bailey et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
- (2013) Sunder Mudaliar et al. GASTROENTEROLOGY
- Intestinal CYP3A4 protects against lithocholic acid-induced hepatotoxicity in intestine-specific VDR-deficient mice
- (2013) Jie Cheng et al. JOURNAL OF LIPID RESEARCH
- Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity
- (2013) Fei Li et al. Nature Communications
- Brain endogenous liver X receptor ligands selectively promote midbrain neurogenesis
- (2012) Spyridon Theofilopoulos et al. Nature Chemical Biology
- Activation of bile salt nuclear receptor FXR is repressed by pro-inflammatory cytokines activating NF-κB signaling in the intestine
- (2011) Raffaella M. Gadaleta et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease
- (2011) R. M. Gadaleta et al. GUT
- Expression of the nuclear bile acid receptor/farnesoid X receptor is reduced in human colon carcinoma compared to nonneoplastic mucosa independent from site and may be associated with adverse prognosis
- (2011) Sigurd Lax et al. INTERNATIONAL JOURNAL OF CANCER
- Inactivation of the vitamin D receptor in APCmin/+ mice reveals a critical role for the vitamin D receptor in intestinal tumor growth
- (2011) Wei Zheng et al. INTERNATIONAL JOURNAL OF CANCER
- Lowering Bile Acid Pool Size with a Synthetic Farnesoid X Receptor (FXR) Agonist Induces Obesity and Diabetes through Reduced Energy Expenditure
- (2011) Mitsuhiro Watanabe et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Bile acids and colon cancer: Solving the puzzle with nuclear receptors
- (2011) Chiara Degirolamo et al. TRENDS IN MOLECULAR MEDICINE
- The Chromosomal Instability Pathway in Colon Cancer
- (2010) Maria S. Pino et al. GASTROENTEROLOGY
- Hydrophobic Bile Acid-Induced Micronuclei Formation, Mitotic Perturbations, and Decreases in Spindle Checkpoint Proteins: Relevance to Genomic Instability in Colon Carcinogenesis
- (2010) Claire M. Payne et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- The Intestinal Nuclear Receptor Signature With Epithelial Localization Patterns and Expression Modulation in Tumors
- (2009) Salvatore Modica et al. GASTROENTEROLOGY
- Deoxycholic Acid and Selenium Metabolite Methylselenol Exert Common and Distinct Effects on Cell Cycle, Apoptosis, and MAP Kinase Pathway in HCT116 Human Colon Cancer Cells
- (2009) Huawei Zeng et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Nuclear Bile Acid Receptor FXR Protects against Intestinal Tumorigenesis
- (2008) S. Modica et al. CANCER RESEARCH
- FXR: a metabolic regulator and cell protector
- (2008) Yan-Dong Wang et al. CELL RESEARCH
- Farnesoid X Receptor Deficiency in Mice Leads to Increased Intestinal Epithelial Cell Proliferation and Tumor Development
- (2008) R. R.M. Maran et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- The Antiapoptotic Role of Pregnane X Receptor in Human Colon Cancer Cells
- (2007) Jie Zhou et al. MOLECULAR ENDOCRINOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More